Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Net Income: 2018-2021

Historic Net Income for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2021 value amounting to -$25.5 million.

  • Black Diamond Therapeutics' Net Income fell 16.25% to -$25.5 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$111.6 million, marking a year-over-year decrease of 68.00%. This contributed to the annual value of -$123.4 million for FY2021, which is 88.32% down from last year.
  • Latest data reveals that Black Diamond Therapeutics reported Net Income of -$25.5 million as of Q4 2021, which was up 26.30% from -$34.6 million recorded in Q3 2021.
  • In the past 5 years, Black Diamond Therapeutics' Net Income ranged from a high of -$3.0 million in Q4 2018 and a low of -$34.6 million during Q3 2021.
  • Over the past 3 years, Black Diamond Therapeutics' median Net Income value was -$14.3 million (recorded in 2020), while the average stood at -$16.8 million.
  • Data for Black Diamond Therapeutics' Net Income shows a maximum YoY plummeted of 235.30% (in 2020) over the last 5 years.
  • Quarterly analysis of 4 years shows Black Diamond Therapeutics' Net Income stood at -$3.0 million in 2018, then tumbled by 225.15% to -$9.9 million in 2019, then slumped by 121.42% to -$21.9 million in 2020, then dropped by 16.25% to -$25.5 million in 2021.
  • Its Net Income was -$25.5 million in Q4 2021, compared to -$34.6 million in Q3 2021 and -$29.6 million in Q2 2021.